[1. Singh VK, Tripathi P. Gene therapy in ocular diseases. Indian J Ophthalmol. 2002; 50:173-81.]Search in Google Scholar
[2. Marshall E. Gene therapy’s growing pains. Science. 1995; 269:1050, 1052-5.10.1126/science.76525527652552]Open DOISearch in Google Scholar
[3. Felgner PL, Barenholz Y, Behr JP, et al. Nomenclature for synthetic gene delivery systems. Hum Gene Ther. 1997; 8:511-2.10.1089/hum.1997.8.5-5119095402]Open DOISearch in Google Scholar
[4. Marshall E. Gene therapy death prompts review of adenovirus vector. Science. 1999; 286:2244-5.10.1126/science.286.5448.224410636774]Open DOISearch in Google Scholar
[5. Hacein-Bey-Abina S, Le Deist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med. 2002; 346:1185-93.10.1056/NEJMoa01261611961146]Open DOISearch in Google Scholar
[6. Grisham J. Inquiry into gene therapy widens. Nat Biotechnol. 2000; 18:254-5.10.1038/7367310700127]Open DOISearch in Google Scholar
[7. Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science. 1990; 247:1465-8.10.1126/science.16909181690918]Open DOISearch in Google Scholar
[8. Wolff JA, Ludtke JJ, Acsadi G, Williams P, Jani A. Longterm persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet. 1992; 1: 363-9.10.1093/hmg/1.6.3631301910]Open DOISearch in Google Scholar
[9. Felgner PL, Gadek TR, Holm M, et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA. 1987; 84:7413-7.10.1073/pnas.84.21.74132993062823261]Open DOISearch in Google Scholar
[10. Stechschulte SU, Joussen AM, von Recum HA, et al. Rapid ocular angiogenic control via naked DNA delivery to cornea. Invest Ophthalmol Vis Sci. 2001; 42:1975-9.]Search in Google Scholar
[11. Hernot S, Klibanov AL. Microbubbles in ultrasoundtriggered drug and gene delivery. Adv Drug Deliv Rev. 2008; 60:1153-66.10.1016/j.addr.2008.03.005272015918486268]Open DOISearch in Google Scholar
[12. Bekeredjian R, Chen S, Pan W, Grayburn PA, Shohet RV. Effects of ultrasound-targeted microbubble destruction on cardiac gene expression. Ultrasound Med Biol. 2004; 30:539-43.10.1016/j.ultrasmedbio.2003.12.00615121256]Open DOISearch in Google Scholar
[13. Guo DP, Li XY, Sun P, et al. Ultrasound/microbubble enhances foreign gene expression in ECV304 cells and murine myocardium. Acta Biochim Biophy Sin. 2004; 36:824-31.10.1093/abbs/36.12.824]Open DOISearch in Google Scholar
[14. Hu YZ, Zhu JA, Jiang YG, Hu B. Ultrasound microbubble contrast agents: application to therapy for peripheral vascular disease. Adv Ther. 2009; 26:425-34.10.1007/s12325-009-0020-y]Open DOISearch in Google Scholar
[15. Zhang Q, Wang Z, Ran H, et al. Enhanced gene delivery into skeletal muscles with ultrasound and microbubble techniques. Acad Radiol. 2006; 13:363-7.10.1016/j.acra.2005.11.003]Open DOISearch in Google Scholar
[16. Wang JF, Wang JB, Chen H, et al. Ultrasound-mediated microbubble destruction enhances gene transfection in pancreatic cancer cells. Adv Ther. 2008; 25:412-21.10.1007/s12325-008-0051-9]Open DOISearch in Google Scholar
[17. Gramiak R, Shah PM. Echocardiography of the aortic root. Invest Radiol. 1968; 3:356-66.10.1097/00004424-196809000-00011]Open DOISearch in Google Scholar
[18. Feinstein SB, Ten Cate FJ, Zwehl W, et al. Twodimensional contrast echocardiography: in vitro development and quantitative-analysis of echo contrast agents. J Am Coll Cardiol. 1984; 3:14-20.10.1016/S0735-1097(84)80424-6]Open DOISearch in Google Scholar
[19. Feinstein SB, Cheirif J, Ten Cate FJ, et al. Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical-results. J Am Coll Cardiol. 1990; 16:316-24.10.1016/0735-1097(90)90580-I]Open DOISearch in Google Scholar
[20. Korpanty G, Grayburn PA, Shohet RV, Brekken RA. Targeting vascular endothelium with avidin microbubbles. Ultrasound Med Biol. 2005; 31:1279-83.10.1016/j.ultrasmedbio.2005.06.001]Open DOISearch in Google Scholar
[21. Frenkel PA, Chen S, Thai T, Shohet RV, Grayburn PA. DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med Biol. 2002; 28:817-22.10.1016/S0301-5629(02)00518-5]Open DOISearch in Google Scholar
[22. Lentacker I, De Geest BG, Vandenbroucke RE, et al. Ultrasound-responsive polymer-coated microbubbles that bind and protect DNA. Langmuir. 2006; 22:7273-8.10.1021/la060382816893226]Open DOISearch in Google Scholar
[23. Porter TR, Xie F. Visually discernible myocardial echocardiographic contrast after intravenous injection of sonicated dextrose albumin microbubbles containing high molecular weight, less soluble gases. J Am Coll Cardiol. 1995; 25:509-15.10.1016/0735-1097(94)00376-2]Open DOISearch in Google Scholar
[24. Correas JM, Quay SD. EchoGen emulsion: a new ultrasound contrast agent based on phase shift colloids. Clin Radiol. 1996; 51(suppl.1):11-4.]Search in Google Scholar
[25. Schneider M, Arditi M, Barrau MB, et al. BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Invest Radiol. 1995; 30:451-5.10.1097/00004424-199508000-00001]Open DOISearch in Google Scholar
[26. Laing ST, McPherson DD. Cardiovascular therapeutic uses of targeted ultrasound contrast agents. Cardiovasc Res. 2009; 83:626-35.10.1093/cvr/cvp192]Open DOISearch in Google Scholar
[27. Skyba DM, Price RJ, Linka AZ, Skalak TC, Kaul S. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation. 1998; 98:290-3.10.1161/01.CIR.98.4.290]Open DOISearch in Google Scholar
[28. Lawrie A, Brisken AF, Francis SE, et al. Ultrasound enhances reporter gene expression after transfection of vascular cells in vitro. Circulation.1999; 99:2617-20.10.1161/01.CIR.99.20.2617]Open DOISearch in Google Scholar
[29. Ward M, Wu J, Chiu JF. Ultrasound-induced cell lysis and sonoporation enhanced by contrast agents. J Acoust Soc Am. 1999; 105:2951-7.10.1121/1.426908]Open DOISearch in Google Scholar
[30. Wu J, Ross JP, Chiu JF. Reparable sonoporation generated by microstreaming. J Acoust Soc Am. 2002; 111:1460-4.10.1121/1.1420389]Open DOISearch in Google Scholar
[31. Tachibana K, Uchida T, Ogawa K, Yamashita N, Tamura K. Induction of cell-membrane porosity by ultrasound. Lancet. 1999; 353:1409.10.1016/S0140-6736(99)01244-1]Open DOISearch in Google Scholar
[32. Ogawa K, Tachibana K, Uchida T, et al. High-resolution scanning electron microscopic evaluation of cellmembrane porosity by ultrasound. Med Electron Microsc. 2001; 34:249-53.10.1007/s00795010002211956998]Open DOISearch in Google Scholar
[33. van Wamel A, Bouakaz A, Versluis M, de Jong N. Micromanipulation of endothelial cells: ultrasoundmicrobubble- cell interaction. Ultrasound Med Biol. 2004; 30:1255-8.10.1016/j.ultrasmedbio.2004.07.01515550330]Open DOISearch in Google Scholar
[34. Miller DL, Gies RA. The interaction of ultrasonic heating and cavitation in vascular bioeffects on mouse intestine. Ultrasound Med Biol. 1998; 24:123-8.10.1016/S0301-5629(97)00209-3]Open DOISearch in Google Scholar
[35. Farjo R, Skaggs J, Quiambao AB, Cooper MJ, Naash MI. Efficient non-viral ocular gene transfer with compacted DNA nanoparticles. PLoS One. 2006; 1:e38.10.1371/journal.pone.0000038]Open DOISearch in Google Scholar
[36. Martin KR, Quigley HA. Gene therapy for optic nerve disease. Eye. 2004; 18:1049-55.10.1038/sj.eye.6701579]Open DOISearch in Google Scholar
[37. Zderic V, Clark JI, Martin RW, Vaezy S. Ultrasoundenhanced transcorneal drug delivery. Cornea. 2004; 23: 804-11.10.1097/01.ico.0000134189.33549.cc]Open DOISearch in Google Scholar
[38. Zderic V, Clark JI, Vaezy S. Drug delivery into the eye with the use of ultrasound. J Ultrasound Med. 2004; 23:1349-59.10.7863/jum.2004.23.10.1349]Open DOISearch in Google Scholar
[39. Zderic V, Vaezy S, Martin RW, Clark JI. Ocular drug delivery using 20-kHz ultrasound. Ultrasound Med Biol. 2002; 28:823-9.10.1016/S0301-5629(02)00515-X]Open DOISearch in Google Scholar
[40. Sonoda S, Tachibana K, Uchino E, et al. Gene transfer to corneal epithelium and keratocytes mediated by ultrasound with microbubbles. Invest Ophthalmol Vis Sci. 2006; 47:558-64.10.1167/iovs.05-088916431951]Open DOISearch in Google Scholar
[41. Wu Y, Du LF, Chen YD, Wang HP, Wang F. SonoVue and ultrasound mediated pEGFP-N1 transfection to mouse cornea in vivo study. Chin J Ultrasonogr. 2008; 17:350-3.]Search in Google Scholar
[42. Yamashita T, Sonoda S, Suzuki R, et al. A novel bubble liposome and ultrasound-mediated gene transfer to ocular surface: RC-1 cells in vitro and conjunctiva in vivo. Exp Eye Res. 2007; 85:741-8.10.1016/j.exer.2007.08.00617889849]Search in Google Scholar
[43. Li W, Liu S, Ren J, Xiong H, Yan X, Wang Z. Gene transfection to retinal ganglion cells mediated by ultrasound microbubbles in vitro. Acad Radiol. 2009; 16:1086-94.10.1016/j.acra.2009.03.01919541507]Open DOISearch in Google Scholar
[44. Mori K, Duh E, Gehlbach P, et al. Pigment epitheliumderived factor inhibits retinal and choroidal neovascularization. J Cell Physiol. 2001; 188:253-63.10.1002/jcp.111411424092]Open DOISearch in Google Scholar
[45. Duh EJ, Yang HS, Suzuma I, et al. Pigment epitheliumderived factor suppresses ischemia-induced retinal neovascularization and VEGF induced migration and growth. Invest Ophthalmol Vis Sci. 2002; 43:821-9.]Search in Google Scholar
[46. Lai CC, Wu WC, Chen SL, et al. Suppression of choroidal neovascularization by adenoassociated virus vector expressing angiostatin. Invest Ophthalmol Vis Sci. 2001; 42:2401-7.]Search in Google Scholar
[47. Takahashi T, Nakamura T, Hayashi A, et al. Inhibition of experimental choroidal neovascularization y overexpression of tissue inhibitor of metalloproteinases-3 in retinal pigment epithelium cells. Am J Ophthalmol. 2000; 130:774-81.10.1016/S0002-9394(00)00772-8]Open DOISearch in Google Scholar
[48. Zhou XY, Liao Q, Pu YM, et al. Ultrasound-mediated microbubble delivery of pigment epithelium-derived factor gene into retina inhibits choroidal neovascularization. Chin Med J. 2009; 122:2711-7.]Search in Google Scholar
[49. Zhou XY, Deng X, Wang ZG. Experimental research of transfection efficiency for EGFP plasmid transfected into retinoblastoma cells by ultrasound microbubble intensifier. Chinese J Ultrasound Med. 2006; 122: 564-6.]Search in Google Scholar
[50. Surace EM, Auricchio A. Versatility of AAV vectors for retinal gene transfer. Vision Res. 2008; 48:353-9.10.1016/j.visres.2007.07.027]Open DOISearch in Google Scholar
[51. Martin KR, Klein RL, Quigley HA. Gene delivery to the eye using adeno-associated viral vectors. Methods. 2002; 28:267-75.10.1016/S1046-2023(02)00232-3]Open DOISearch in Google Scholar
[52. Daya S, Berns KI. Gene therapy using adeno-associated virus vectors. Clin Microbiol Rev. 2008; 21:583-93.10.1128/CMR.00008-08257015218854481]Open DOISearch in Google Scholar
[53. Li HL, Zheng XZ, Wang HP, Li F, Wu Y, Du LF. Ultrasound-targeted microbubble destruction enhances AAV-mediated gene transfection in human RPE cells in vitro and rat retina in vivo. Gene Ther. 2009; 16:1146-53.10.1038/gt.2009.8419571889]Open DOISearch in Google Scholar
[54. Zheng XZ, Li HL, Du LF, Wang HP, Gu Qing. In vivo and in vitro effects of ultrasound or/and microbubbles on recombinant adeno-associated virus-mediated transgene expression in the retina. Asian Biomed. 2009; 3:497-506.]Search in Google Scholar
[55. Baum C, Kustikova O, Modlich U, Li Z, Fehse B. Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum Gene Ther. 2006; 17:253-63.10.1089/hum.2006.17.25316544975]Open DOISearch in Google Scholar
[56. Halbert CL, Miller AD, McNamara S, et al. Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors. Hum Gene Ther. 2006; 17:440-7.10.1089/hum.2006.17.440429289016610931]Open DOISearch in Google Scholar
[57. Raper SE, Chirmule N, Lee FS, et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab. 2003; 80: 148-58.10.1016/j.ymgme.2003.08.01614567964]Open DOISearch in Google Scholar
[58. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 2003; 4:346-58.10.1038/nrg106612728277]Open DOISearch in Google Scholar
[59. Cai X, Conley S, Naash M. Nanoparticle Applications in Ocular Gene Therapy. Vision Res. 2008; 48:319-24.10.1016/j.visres.2007.07.012242334517825344]Open DOISearch in Google Scholar
[60. Bejjani RA, BenEzra D, Cohen H, et al. Nanoparticles for gene delivery to retinal pigment epithelial cells. Mol Vis. 2005; 11:124-32.]Search in Google Scholar
[61. de la Fuente M, Seijo B, Alonso MJ. Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy. Invest Ophthalmol Vis Sci. 2008; 49:2016-24.10.1167/iovs.07-1077]Open DOISearch in Google Scholar
[62. Chappell JC, Song J, Burke CW, Klibanov AL, Price RJ. Targeted delivery of nanoparticles bearing fibroblast growth factor-2 by ultrasonic microbubble destruction for therapeutic arteriogenesis. Small. 2008; 4:1769-77.10.1002/smll.200800806]Search in Google Scholar
[63. Vancraeynest D, Havaux X, Pouleur AC, et al. Myocardial delivery of colloid nanoparticles using ultrasound-targeted microbubble destruction. Eur Heart J. 2006; 27:237-45.10.1093/eurheartj/ehi479]Open DOISearch in Google Scholar
[64. Lin CY, Liu TM, Chen CY, Huang YL, Huang WK, Sun CK, Chang FH, Lin WL. Quantitative and qualitativeinvestigation into the impact of focused ultrasound with microbubbles on the triggered release of nanoparticles from vasculature in mouse tumors. J Control Release. 2010; 146:291-8.10.1016/j.jconrel.2010.05.033]Open DOISearch in Google Scholar
[65. Chumakova OV, Liopo AV, Andreev VG, et al. Composition of PLGA and PEI/DNA nanoparticles improves ultrasound-mediated gene delivery in solid tumors in vivo. Cancer Lett. 2008; 261:215-25.10.1016/j.canlet.2007.11.023]Open DOISearch in Google Scholar
[66. Larina IV, Evers BM, Ashitkov TV, Bartels C, Larin KV, Esenaliev RO. Enhancement of drug delivery in tumors by using interaction of nanoparticles with ultrasound radiation. Technol Cancer Res Treat. 2005; 4:217-26.10.1177/153303460500400211]Open DOISearch in Google Scholar
[67. Larina IV, Evers BM, Esenaliev RO. Optimal drug and gene delivery in cancer cells by ultrasound-induced cavitation. Anticancer Res. 2005; 25:149-56.]Search in Google Scholar
[68. Pitkänen L, Pelkonen J, Ruponen M, Rönkkö S, Urtti A. Neural retina limits the nonviral gene transfer to retinal pigment epithelium in an in vitro bovine eye model. AAPS J. 2004; 6:e25.10.1208/aapsj060325]Open DOISearch in Google Scholar
[69. Peeters L, Lentacker I, Vandenbroucke RE, et al. Can Ultrasound Solve the Transport Barrier of the Neural Retina? Pharm Res. 2008; 25:2657-65.10.1007/s11095-008-9684-2]Open DOISearch in Google Scholar
[70. Cunha-Vaz J. The blood-ocular barriers. Surv Ophthalmol. 1979; 23:279-96.10.1016/0039-6257(79)90158-9]Open DOISearch in Google Scholar
[71. Meairs S, Alonso A. Ultrasound, microbubbles and the blood-brain barrier. Prog Biophys Mol Biol. 2007; 93:354-62.10.1016/j.pbiomolbio.2006.07.01916959303]Open DOISearch in Google Scholar
[72. Sheikov N, McDannold N, Vykhodtseva N, Jolesz F, Hynynen K. Cellular mechanisms of the blood-brain barrier opening induced by ultrasound in presence of microbubbles.Ultrasound Med Biol. 2004; 30: 979-89.10.1016/j.ultrasmedbio.2004.04.01015313330]Open DOISearch in Google Scholar
[73. Xu Y, Zhou XY, Wang ZG, Li XS. Experimental study on transferring EGFP gene into the retina of rat mediated by microbubbles. Chin J Med Imaging Technol. 2007; 23:188-90.]Search in Google Scholar
[74. Saito K, Miyake K, McNeil PL, Kato K, Yago K, Sugai N. Plasma membrane disruption underlies injury of the corneal endothelium by ultrasound. Exp Eye Res. 1999; 68:431-7. 10.1006/exer.1998.062610192800]Open DOISearch in Google Scholar